PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportspyoderma gangrenosum
MeSH D017511 - pyoderma gangrenosum
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017445:Vascular skin diseases
0 Companies
0 Drugs
Success rate
D012883:Skin ulcer
9 Companies
9 Drugs
$
Success rate
D011711:Pyoderma
0 Companies
0 Drugs
Success rate
D017511: 
Pyoderma gangrenosum
2 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
25%
2/8
Phase 3
50%
2/4
Approved: 2Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Clofazimine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use